Found 0 matching trials
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder PHASE3 Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Show More Location
Multiple Locations
Learn More & Join Trial
Awake vs. Asleep Craniotomy for Non-eloquent Gliomas NA This study protocol examines a comparison between local and general anesthe...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
ALN-APOC3 in Adult Participants With Dyslipidemia PHASE1 This study is researching an experimental drug called ALN-APOC3 (called "st...
Show More Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Learn More & Join Trial
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis PHASE1 MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Show More Learn More & Join Trial
A Study of NH280105 in Healthy Adult Participants PHASE1 This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Show More Location
CMAX Clinical Research Pty Ltd
Learn More & Join Trial
The MASS COMM Post-Randomization Phase Cohort Study NA The primary objective of the Post-Randomization Phase Cohort Study is to co...
Show More Location
Good Samaritan Medical Center
Learn More & Join Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
CD4 CAR+ ZFN-modified T Cells in HIV Therapy PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury. PHASE2 A Randomized, Double Blind, Placebo Controlled, Phase 2 Dose Escalation Stu...
Show More Location
Site Reference ID/Investigator# 45771
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants PHASE1 This study is a phase I, single-center, randomized, double-blind, placebo-c...
Show More Learn More & Join Trial